Biomolecular Life Holdings, Inc. (BIOM)
OTCMKTS · Delayed Price · Currency is USD
0.8300
-0.1600 (-16.16%)
Oct 13, 2026, 2:43 PM EDT
BIOM Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Cash & Equivalents | - | - | - | 0.03 | 0.71 | 0.01 |
Cash & Short-Term Investments | - | - | - | 0.03 | 0.71 | 0.01 |
Cash Growth | - | - | - | -95.24% | 11620.44% | 5.29% |
Prepaid Expenses | - | - | - | 0.21 | 0.08 | - |
Total Current Assets | 0 | - | - | 0.25 | 0.79 | 0.01 |
Property, Plant & Equipment | 0.4 | - | - | - | - | - |
Other Intangible Assets | - | - | - | 1.08 | 1.08 | 1.08 |
Total Assets | 0.4 | - | - | 1.32 | 1.87 | 1.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Accounts Payable | 0.06 | - | - | 0.71 | 0.41 | 0.39 |
Accrued Expenses | 1.33 | 1.27 | 1.02 | 0.6 | 0.54 | 0.61 |
Short-Term Debt | 0.51 | 0.49 | 0.45 | 3.86 | 3.21 | 3.57 |
Other Current Liabilities | 2.43 | 1.43 | 1.37 | 0.66 | 2.18 | 0.71 |
Total Current Liabilities | 4.33 | 3.19 | 2.84 | 5.83 | 6.33 | 5.28 |
Total Liabilities | 4.33 | 3.19 | 2.84 | 5.83 | 6.33 | 5.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 112.88 | 112.41 | 112.41 | 100.79 | 94.61 | 87.46 |
Retained Earnings | -116.83 | -115.6 | -115.25 | -105.97 | -99.78 | -92.36 |
Total Common Equity | -3.94 | -3.2 | -2.85 | -5.17 | -5.17 | -4.9 |
Minority Interest | - | - | - | 0.66 | 0.7 | 0.7 |
Shareholders' Equity | -3.93 | -3.19 | -2.84 | -4.51 | -4.47 | -4.2 |
Total Liabilities & Equity | 0.4 | - | - | 1.32 | 1.87 | 1.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Total Debt | 0.51 | 0.49 | 0.45 | 3.86 | 3.21 | 3.57 |
Net Cash (Debt) | -0.51 | -0.49 | -0.45 | -3.83 | -2.49 | -3.56 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.13 | -0.46 | -0.42 | - | - | - |
Filing Date Shares Outstanding | 51.16 | 1.06 | 1.05 | - | - | - |
Total Common Shares Outstanding | 51.16 | 1.06 | 1.05 | - | - | - |
Working Capital | -4.33 | -3.19 | -2.84 | -5.58 | -5.55 | -5.27 |
Book Value Per Share | -0.08 | -3.01 | -2.70 | - | - | - |
Tangible Book Value | -3.94 | -3.2 | -2.85 | -6.25 | -6.25 | -5.97 |
Tangible Book Value Per Share | -0.08 | -3.01 | -2.70 | - | - | - |